Qrons INC
Market Movers (8-K)
QRON
Qrons INCQrons Inc. announces the launch of its 'Think Fast' functional coffee product and provides an update on operational recovery and SEC filing status.
Delay expected
Capital raise
QRON
Qrons INCQrons Inc. acknowledges shareholder frustration over fiscal 2025 delays, announcing an operational restart for its First Person brand, new supplier, strategic partner, and upcoming product launch.
Delay expected
Worse than expected
Capital raise
QRON
Qrons INCQrons Inc. provides a comprehensive shareholder update, outlining its strategic direction as a cognitive performance company and addressing a temporary transition from OTCQB to OTC Expert market due to delayed SEC filings.
Worse than expected
Capital raise
Delay expected
QRON
Qrons INC8-K: Qrons Inc. Changes Accounting Firms: Appoints LAO Professionals, Dismisses OLAYINKA OYEBOLA & CO.
Qrons Inc. announces the dismissal of its former independent registered public accounting firm, OLAYINKA OYEBOLA & CO., and the appointment of LAO Professionals as its new auditor, effective immediately.
QRON
Qrons INCQrons Inc. dismisses Green Growth CPAs and appoints OLAYINKA OYEBOLA & CO. as its new independent registered public accounting firm, effective immediately on March 12, 2025.
Worse than expected
QRON
Qrons INCQrons Inc. finalizes its merger with First Person Ltd., establishing a publicly traded entity focused on cognitive wellness and functional beverages.
Capital raise
Worse than expected
Quarterly Earnings (10-Q)
QRON
Qrons INCQrons Inc. has released its third quarter 2024 financial results, showing a reduced net loss compared to the previous year, and has announced a merger agreement with First Person Ltd.
Better than expected
Capital raise
QRON
Qrons INCQrons Inc. reported a net loss of $109,266 for the three months ended June 30, 2024, a significant increase compared to the $12,746 loss in the same period of 2023, primarily due to increased research and development expenses.
Delay expected
Worse than expected
Capital raise
QRON
Qrons INCQrons Inc. reported a net loss of $42,616 for the first quarter of 2024, with increased research and development expenses and ongoing efforts to secure additional funding.
Worse than expected
Capital raise
Annual Reports (10-K)
QRON
Qrons INC10-K: Qrons Inc. Secures $250,000 in Convertible Debt Financing to Fuel Cognitive Wellness Expansion
Qrons Inc. enters into a series of note purchase agreements to secure $250,000 in convertible debt financing, aimed at supporting general working capital and expanding its cognitive wellness business.
Capital raise
QRON
Qrons INCQrons Inc.'s 10-K filing details a shift in focus towards developing treatments for sepsis and antibiotic-resistant bacteria, alongside ongoing research in traumatic brain injuries.
Capital raise
Worse than expected